Myeloablative Fractionated Busulfan Conditioning Regimen with Sorafenib in Patients with AML: Results of Phase I Clinical Trial
暂无分享，去创建一个
P. Thall | K. Rezvani | D. Marin | E. Shpall | F. Ravandi | N. Daver | B. Andersson | B. Valdez | Y. Nieto | U. Popat | Q. Bashir | M. Qazilbash | A. Alousi | R. Champlin | R. Mehta | C. Hosing | P. Kebriaei | B. Oran | J. Ramdial | G. Alatrash | A. Olson | Jin S Im | S. Srour | N. Saini | R. Bassett